A low-cost, rapid diagnostic test for COVID-19 developed by Penn Medicine provides COVID-19 results within four minutes with 90 percent accuracy. A paper published this week in Matter details the fast and inexpensive diagnostic test, called RAPID 1.0. Compared to existing methods for COVID-19 detection, RAPID is inexpensive and highly scalable, allowing the production of millions of units per week.
The National Institutes of Health today announced three new contracts and one new award to an existing contract for scale-up and manufacturing of novel COVID-19 testing technologies. The four Rapid Acceleration of Diagnostics initiative contracts totals $65.6 million.